Blog & News

  • All
  • Blog
  • News

The Application of AIRR Patient Profiling in B Cell Depletion and Immune Resetting Therapies for Autoimmune Disorders

Apr 22, 2026
READ MORE

From Bulk to Single-Cell: Choosing the Right Immune Repertoire Workflow for Your Program

Feb 9, 2026
READ MORE

Identifying the origin of omental tumor Tregs with TCRβ sequencing

Jun 28, 2022
READ MORE

A newly characterized T cell population important for cancer immunosurveillance

Jun 28, 2022
READ MORE

The specific γδ TCR repertoire in response to malaria

Dec 13, 2021
READ MORE
Moving toward T cell therapy for COVID-19 with single cell immune sequencing

T cell therapy for COVID-19 with single cell immune sequencing

Jul 26, 2021
READ MORE
The evolution of antibody-based treatments for infectious disease: From convalescent plasma to single cell immune sequencing. Read case study.

The evolution of antibody-based treatments for infectious disease: From convalescent plasma to single cell immune sequencing

Apr 15, 2021
READ MORE
Immune repertoire sequencing for pre- and post-treatment monitoring in cancer. Read case study.

Immune Repertoire Sequencing for Pre- and Post-Treatment Monitoring in Cancer

Apr 14, 2021
READ MORE

New discovery in malaria blazes a trail for developing antibody-based treatments for COVID-19

Mar 19, 2021
READ MORE
Predicting and measuring patient response to cell therapy with single cell TCR sequencing. Read case study.

Predicting and measuring patient response to cell therapy with single cell TCR sequencing

Jan 20, 2021
READ MORE
Using TCR diversity to model progression-free cancer survival. Surprising parallels with chronic viral infection. Ready study.

New study models TCR repertoire as a biomarker for immunotherapy response—reveals surprising signatures of PFS

Dec 14, 2020
READ MORE
Finding new immunotherapy targets in cancer research. Read study.

Finding new therapeutic targets in cancer research through changes in the immune adaptome

Nov 2, 2020
READ MORE
iPair single cell sequencing demonstrates efficacy of in vitro/in vivo t-cell therapy

Cue Biopharma uses iPair technology to demonstrate efficacy of Tumor Antigen-Specific T Cell activating drug

Oct 29, 2020
READ MORE
A radar map of the immune system's response to COVID-19, published by scientists who discovered SARS

Scientists who discovered SARS just revealed a radar map of the immune system’s response to COVID-19

Oct 19, 2020
READ MORE

Ready to get started?

Let's chat about your project